Synthesis approach utilizes o-vinylhydroxylamines for ring-annulation, implying efficacy in creating azaindoles.
We report a convenient and scalable strategy for the synthesis of 7-azaindolines and 7-azaindoles using O-vinylhydroxylamines as ring-annulation reagents. These fused nitrogen-containing heterocycles are prominent in numerous biologically active molecules, including FDA-approved pharmaceuticals. Traditional synthetic approaches to these motifs often rely on costly transition metal catalysts and/or high-temperature conditions, such as those employed in the Larock and Fischer indole syntheses. In our approach, O-vinylhydroxylamines undergo N-arylation with aza-arene N-oxides, triggering a rapid [3,3]-sigmatropic rearrangement. This is followed by re-aromatization and cyclization to deliver 7-azaindolines, which can be readily dehydrated to afford the corresponding 7-azaindoles. The method offers a broad substrate scope, enabling access to a diverse array of highly functionalized derivatives. Moreover, the mild reaction conditions facilitate late-stage functionalization of complex molecules, demonstrating their value in both synthetic and medicinal chemistry.
No takes yet. Share an insight, caveat, or question.
Grimm et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: